Greenland Mines Ltd. (NASDAQ: GRML) has officially commenced its 2026 field season at the Skaergaard Project, marking a significant step forward in the company's exploration and development efforts. The company's support vessel, Argus, departed Reykjavik, Iceland, for southeast Greenland, carrying drill rigs, geophysical equipment, drone survey systems, bulk-sampling machinery, fuel, and other essential exploration infrastructure. The initial field team comprises more than 40 technical experts, drillers, and logistics personnel, with additional specialists scheduled to rotate in throughout the season.
The comprehensive program encompasses resource drilling, bulk sampling, environmental baseline studies, geotechnical and engineering work, and advanced aerial and ground-based surveys. These activities are designed to support a resource upgrade and advance the project toward its next development phase, including evaluation of a potential initial open-pit mining scenario alongside existing underground mining concepts. This dual-mining approach underscores the company's commitment to optimizing the project's economic viability and operational flexibility.
The Skaergaard Project, located in southeast Greenland, is a key asset in Greenland Mines' portfolio. The company's strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision. This vision aims to link Greenland resources with allied downstream jurisdictions and industrial infrastructure, positioning the company strategically in the global supply chain for critical minerals.
In addition to the Skaergaard Project, Greenland Mines has two operating divisions: Mining and Biotech. The Mining division is focused on the exploration and development of the Skaergaard Project and, subject to closing of a previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland. The Biotech division includes Klotho's KLTO-202 primary indication for ALS, reflecting the company's diversified approach to growth.
The commencement of the field season is a critical milestone for Greenland Mines as it seeks to de-risk the Skaergaard Project and attract potential partners or investors. The extensive work planned for this season will provide valuable data that could lead to an updated mineral resource estimate, which is essential for feasibility studies and eventual mine development. Moreover, the focus on environmental baseline studies highlights the company's commitment to responsible and sustainable mining practices, which is increasingly important in the eyes of regulators, investors, and local communities.
For more information on the full press release, visit https://ibn.fm/VGQNA. The latest news and updates relating to GRML are available in the company's newsroom at https://ibn.fm/GRML.
